Results 21 to 30 of about 22,419 (100)

A case-control study of anaemia in patients with rheumatoid arthritis treated with disease-modifying antirheumatic drugs in an adult population in the US: prevalence and impact on healthcare utilisation [PDF]

, 2008
Chenglong Han, N. Zhao, Mahboob U. Rahman, Mittie K. Doyle, Mohan Bala   +4 more
openalex   +1 more source

The Gap Between Practice and Guidelines in the Choice of First-line Disease Modifying Antirheumatic Drug in Early Rheumatoid Arthritis: Results from the ESPOIR Cohort [PDF]

, 2009
Mathilde Benhamou, Nathalie Rincheval, Carine Roy, Violaine Foltz, Sylvie Rozenberg, Jean Sibilia, Thierry Schaeverbeke, Pierre Bourgeois, Philippe Ravaud, Bruno Fautrel   +9 more
openalex   +1 more source

Initiation Patterns of Disease-Modifying Antirheumatic Drugs That Have Potential to Exacerbate Heart Failure. [PDF]

J Am Heart Assoc, 2023
Lee SB, D'Andrea E, Desai RJ.
europepmc   +1 more source

Plasma Adiponectin in Patients with Active, Early, and Chronic Rheumatoid Arthritis Who Are Steroid- and Disease-Modifying Antirheumatic Drug-Naive Compared with Patients with Osteoarthritis and Controls [PDF]

, 2009
Trine Bay Laurberg, Jan Frystyk, Torkell Ellingsen, Ib Tønder Hansen, Anette Jørgensen, Ulrik Tarp, Merete Lund Hetland, Kim Hørslev‐Petersen, Nete Hornung, Jørgen Poulsen, Allan Flyvbjerg, Kristian Stengaard‐Pedersen   +11 more
openalex   +1 more source

Efficacy and toxicity of old and new disease modifying antirheumatic drugs

, 2000
Peter Tugwell
openalex   +1 more source

Rheumatoid Atlantoaxial Subluxation Can Be Prevented by Intensive Use of Traditional Disease Modifying Antirheumatic Drugs [PDF]

, 2009
Markku Kauppi, Marko H. Neva, Kari Laiho, Hannu Kautiainen, Reijo Luukkainen, Anna Karjalainen, Pekka Hannonen, Marjatta Leirisalo‐Repo, Markku Korpela, Kirsti Ilva, Timo Möttönen   +10 more
openalex   +1 more source

FRI0023 Laboratory testing in rheumatoid arthritis patients on disease modifying antirheumatic drugs: clinical evaluation and cost analysis

, 2001
D Aletaha, JS Smolen
openalex   +1 more source

Early combination disease-modifying antirheumatic drug therapy and tight disease control improve long-term radiologic outcome in patients with early rheumatoid arthritis: the 11-year results of the Finnish Rheumatoid Arthritis Combination Therapy trial [PDF]

, 2010
Vappu Rantalaiho, Markku Korpela, Leena Laasonen, Hannu Kautiainen, Salme Järvenpää, Pekka Hannonen, Marjatta Leirisalo‐Repo, Harri Blåfield, Kari Puolakka, Anna Karjalainen, Timo Möttönen   +10 more
openalex   +1 more source

Impact of seropositivity and disease-modifying antirheumatic drugs on pulmonary tuberculosis risk in rheumatoid arthritis. [PDF]

ERJ Open Res
Choi H, Eun Y, Han K, Jung JH, Jung W, Kim H, Shin DW, Lee H.   +7 more
europepmc   +1 more source

Real-World Treatment Effectiveness of Disease-Modifying Antirheumatic Drugs by Serostatus Among Patients With Rheumatoid Arthritis. [PDF]

ACR Open Rheumatol, 2023
Jin Y, Liu J, Desai RJ, Kim SC.
europepmc   +1 more source